TNF Pharmaceuticals, Inc. Soared

TNF Pharmaceuticals, Inc. (TNFA:NASDAQ) jumped higher at $5.2, representing a gain of 48.1%. On Wed, Sep 24, 2025, TNFA:NASDAQ hit a New 2-Week High of $5.2. The stock appeared on our News Catalysts scanner on Wed, Sep 24, 2025 at 10:49 AM in the 'MISCELLANEOUS' category. From Wed, Sep 10, 2025, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Sep 24, 2025 at $8.9 with a volume of 60M+.
About TNF Pharmaceuticals, Inc. (TNFA:NASDAQ)
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Top 10 Gainers:
- uniQure N.V. (QURE:NASDAQ), 247.73%
- SHF Holdings, Inc. (SHFS:NASDAQ), 123.01%
- Smart for Life, Inc. (SMFL:NASDAQ), 100%
- Lithium Americas Corp. (LAC:NYSE), 95.77%
- RedCloud Holdings plc (RCT:NASDAQ), 64.71%
- ClearPoint Neuro, Inc. (CLPT:NASDAQ), 58.55%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 47.68%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 45.96%
- Aqua Metals, Inc. (AQMS:NASDAQ), 44.94%